Back to today’s briefing

Story perspectives

Fujifilm Rebrands to Boost Biomanufacturing for Drug Developers

7/9/2025

49 6

Summary

Story summary

Fujifilm's Life Sciences Group is stepping up its game by rebranding its companies to better serve drug and vaccine developers. Fujifilm Diosynth Biotechnologies is now Fujifilm Biotechnologies, while Fujifilm Irvine Scientific has transformed into Fujifilm Biosciences. This strategic shift aims to bolster biomanufacturing and includes major investments in facilities across Texas and Denmark.

1 of 1

Story summary

Fujifilm's Life Sciences Group is stepping up its game by rebranding its companies to better serve drug and vaccine developers. Fujifilm Diosynth Biotechnologies is now Fujifilm Biotechnologies, while Fujifilm Irvine Scientific has transformed into Fujifilm Biosciences. This strategic shift aims to bolster biomanufacturing and includes major investments in facilities across Texas and Denmark.